Open-label, Uncontrolled, Non-Interventional, Retrospective Study to Evaluate Molecular Determinants of Outcome to the Immune Checkpoint Inhibitors (Anti-PD-1/Anti-PD-L1 Monoclonal Antibodies) Treatment for Solid Tumors

NCT04860076 · clinicaltrials.gov ↗
UNKNOWN
Status
400
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Asylia Diagnostics BV